DeepLife hosts this transformative event, exploring how AI is revealing the hidden potential of existing drugs and creating unprecedented opportunities for maximizing value in today’s competitive pharmaceutical landscape.

Emmanuelle Trombe will join a panel of industry leaders, investors, clinicians, patient advocates and researchers to speak on the exploration of new markets, undiscovered targets and innovative approaches to drug lifecycle management.

To learn more and register, please click here.